Compound Detail
CHEMBL120535
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL120535 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MARXYUXLVABKCN-VAWYXSNFSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
396.5
MW (Da)
2.82
ALogP
6
HBA
2
HBD
84.3
PSA (Ų)
0.45
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 5.22
IC50 1 meas. best 5.28
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus 1 CHEMBL378 | IC50 | 5.28 | 5.28 | 5220.0 | 1 |
| Human immunodeficiency virus CHEMBL613758 | EC50 | 5.22 | 5.22 | 6000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus 1 | IC50 | = | 5220.0 | nM | 5.28 | Antiviral activity against HIV1 3B infected in human MT4 cells assessed as prote... | 24657566 |
| Human immunodeficiency virus | EC50 | = | 6000.0 | nM | 5.22 | Effective concentration required to achieve 50% protection of MT-4 cells against... | 1992136 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 1992136 | 10.1021/jm00105a055 | MT4 | 2 |
| 1992136 | 10.1021/jm00105a055 | Human immunodeficiency virus | 1 |
| 24657566 | 10.1016/j.ejmech.2014.03.013 | Human immunodeficiency virus 1 | 1 |
Data from ChEMBL 36 via Core Engine